- Home
- Publications
- Publication Search
- Publication Details
Title
Liposome and Their Applications in Cancer Therapy
Authors
Keywords
-
Journal
BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY
Volume 59, Issue -, Pages -
Publisher
FapUNIFESP (SciELO)
Online
2016-03-06
DOI
10.1590/1678-4324-2016150477
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
- (2015) S K Srivastava et al. BRITISH JOURNAL OF CANCER
- MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways
- (2015) Sanjeev K Srivastava et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis
- (2015) Sumit Arora et al. Nanomedicine-Nanotechnology Biology and Medicine
- Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation
- (2015) Sachin K. Deshmukh et al. Oncotarget
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- A review on phospholipids and their main applications in drug delivery systems
- (2015) Jing Li et al. Asian Journal of Pharmaceutical Sciences
- CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1
- (2015) Arun Bhardwaj et al. Oncotarget
- p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway
- (2015) Nikhil Tyagi et al. Oncotarget
- Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
- (2014) J. Baselga et al. ANNALS OF ONCOLOGY
- Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
- (2014) J. E. Lancet et al. BLOOD
- Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML
- (2014) Jorge E. Cortes et al. CANCER
- Predicting clinical trial results based on announcements of interim analyses
- (2014) Kristine R Broglio et al. Trials
- Cholesterol level affects surface charge of lipid membranes in saline solution
- (2014) Aniket Magarkar et al. Scientific Reports
- Ligation Strategies for Targeting Liposomal Nanocarriers
- (2014) Patricia Marqués-Gallego et al. Biomed Research International
- A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma†
- (2013) A. C. Roy et al. ANNALS OF ONCOLOGY
- Clinical Application of Drug Delivery Systems in Cancer Chemotherapy: Review of the Efficacy and Side Effects of Approved Drugs
- (2013) Takuya Iwamoto BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
- (2013) A H Ko et al. BRITISH JOURNAL OF CANCER
- Efficacy of Liposomal Monensin on the Enhancement of the Antitumour Activity of Liposomal Ricin in Human Epidermoid Carcinoma (KB) Cells
- (2013) PC Ghosh et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Biotargeted nanomedicines for cancer: six tenets before you begin
- (2013) Michael S Goldberg et al. Nanomedicine
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome
- (2012) Joan Bladé et al. Clinical Lymphoma Myeloma & Leukemia
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Enhanced killing of human epidermoid carcinoma (KB) cells by treatment with ricin encapsulated into sterically stabilized liposomes in combination with monensin
- (2011) Nikhil Tyagi et al. DRUG DELIVERY
- Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: Effect of monensin intercalated into folate-tagged liposomes
- (2011) Nikhil Tyagi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer
- (2011) Ronnie TP Poon et al. Future Oncology
- Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan
- (2011) Kareen Riviere et al. JOURNAL OF CONTROLLED RELEASE
- Localised drug release using MRI-controlled focused ultrasound hyperthermia
- (2010) Robert Staruch et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Immunotherapy for Lung Cancer
- (2010) Penelope A. Bradbury et al. Journal of Thoracic Oncology
- Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma
- (2009) M. A. Rodriguez et al. CANCER
- Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
- (2009) G. Batist et al. CLINICAL CANCER RESEARCH
- Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method
- (2008) Liyan Qiu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Potential chemotherapy side effects: What do oncologists tell parents?
- (2008) Lisa Ysela Ramirez et al. PEDIATRIC BLOOD & CANCER
- Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
- (2007) Ryo Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started